FI915933A0 - Korta peptider som har insulininverkan. - Google Patents

Korta peptider som har insulininverkan.

Info

Publication number
FI915933A0
FI915933A0 FI915933A FI915933A FI915933A0 FI 915933 A0 FI915933 A0 FI 915933A0 FI 915933 A FI915933 A FI 915933A FI 915933 A FI915933 A FI 915933A FI 915933 A0 FI915933 A0 FI 915933A0
Authority
FI
Finland
Prior art keywords
amino acid
peptider
insulin
network
time
Prior art date
Application number
FI915933A
Other languages
English (en)
Other versions
FI915933A (fi
FI105816B (fi
Inventor
Stefan Mullner
Wolfgang Koenig
Gunter Muller
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI915933A0 publication Critical patent/FI915933A0/fi
Publication of FI915933A publication Critical patent/FI915933A/fi
Application granted granted Critical
Publication of FI105816B publication Critical patent/FI105816B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI915933A 1990-12-19 1991-12-17 Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi FI105816B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4040574 1990-12-19
DE4040574 1990-12-19

Publications (3)

Publication Number Publication Date
FI915933A0 true FI915933A0 (fi) 1991-12-17
FI915933A FI915933A (fi) 1992-06-20
FI105816B FI105816B (fi) 2000-10-13

Family

ID=6420676

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915933A FI105816B (fi) 1990-12-19 1991-12-17 Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi

Country Status (24)

Country Link
US (1) US5461035A (fi)
EP (1) EP0491361B1 (fi)
JP (2) JP3378588B2 (fi)
KR (1) KR100237948B1 (fi)
AT (1) ATE177753T1 (fi)
AU (1) AU643349B2 (fi)
CA (1) CA2058020C (fi)
CZ (1) CZ284568B6 (fi)
DE (1) DE59109109D1 (fi)
DK (1) DK0491361T3 (fi)
ES (1) ES2130130T3 (fi)
FI (1) FI105816B (fi)
GR (1) GR3030510T3 (fi)
HR (1) HRP940839B1 (fi)
HU (1) HU222493B1 (fi)
IE (1) IE914408A1 (fi)
IL (1) IL100400A (fi)
NO (1) NO308951B1 (fi)
NZ (1) NZ241029A (fi)
PT (1) PT99850B (fi)
SK (2) SK282361B6 (fi)
TW (1) TW227004B (fi)
YU (1) YU189891A (fi)
ZA (1) ZA919938B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
SE0002716L (sv) * 2000-07-18 2002-01-19 Lars Wahlberg Komposition mot insekter
DE60204847T2 (de) * 2001-01-15 2006-05-11 Société de Technologie Michelin Formgebungstrommel für die reifenherstellung
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101909052B1 (ko) * 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740406A1 (de) * 1977-09-08 1979-03-22 Hoechst Ag Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DD147942A1 (de) * 1979-08-20 1981-04-29 Guenter Losse Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung
FR2525592B1 (fi) * 1982-04-26 1984-09-14 Pasteur Institut

Also Published As

Publication number Publication date
GR3030510T3 (en) 1999-10-29
KR920012115A (ko) 1992-07-25
ZA919938B (en) 1992-09-30
EP0491361B1 (de) 1999-03-17
NO308951B1 (no) 2000-11-20
US5461035A (en) 1995-10-24
IL100400A (en) 1998-01-04
HU222493B1 (hu) 2003-07-28
AU643349B2 (en) 1993-11-11
DE59109109D1 (de) 1999-04-22
TW227004B (fi) 1994-07-21
FI915933A (fi) 1992-06-20
AU8982591A (en) 1992-06-25
HU914009D0 (en) 1992-03-30
NO914999D0 (no) 1991-12-18
PT99850B (pt) 1999-06-30
NZ241029A (en) 1993-01-27
HUT59697A (en) 1992-06-29
HRP940839B1 (en) 2000-02-29
SK282360B6 (sk) 2002-01-07
YU189891A (sh) 1995-10-03
KR100237948B1 (ko) 2000-01-15
IL100400A0 (en) 1992-09-06
IE914408A1 (en) 1992-07-01
CA2058020C (en) 2003-10-28
CA2058020A1 (en) 1992-06-20
JP2003176237A (ja) 2003-06-24
ATE177753T1 (de) 1999-04-15
EP0491361A3 (en) 1993-11-24
DK0491361T3 (da) 1999-10-11
PT99850A (pt) 1992-11-30
FI105816B (fi) 2000-10-13
JPH04295496A (ja) 1992-10-20
SK282361B6 (sk) 2002-01-07
CZ284568B6 (cs) 1999-01-13
JP3378588B2 (ja) 2003-02-17
NO914999L (no) 1992-06-22
ES2130130T3 (es) 1999-07-01
JP3802863B2 (ja) 2006-07-26
EP0491361A2 (de) 1992-06-24
HRP940839A2 (en) 1997-06-30
CS387991A3 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
DK0397420T3 (da) Enzymatisk fjernelse af en aminoterminal proteinsekvens
DE69435105D1 (de) Derivate therapeutischer Peptide
DK0563093T4 (da) Præparat anvendt som terapeutisk middel mod kroniske virale hepatitissygdomme
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
FI923702A0 (fi) Fosfoinositolglykanpeptid med insulinartad verkan.
ES2038675T3 (es) Un procedimiento para preparar compuestos peptidicos.
ES2032896T3 (es) Procedimiento para la preparacion de cristales mixtos a base de insulina y derivados de insulina.
ATE130312T1 (de) Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.
ATE185973T1 (de) Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen
FI915933A0 (fi) Korta peptider som har insulininverkan.
DE60228136D1 (de) Cytokin-proteinfamilie
KR920012114A (ko) 사람 면역결핍 바이러스(HIV)의 그룹-특이 항원(gaa)의 선택된 펩타이드, 이의 제법 및 용도
ES2124954T3 (es) Ciclohexapeptidos y sus mezclas, procedimiento para su preparacion asi como su empleo.
DE69203098D1 (de) Verwendung eines Polypeptids mit humaner Interleukin-2 Aktivität zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Pneumothoraxen.
AU7470681A (en) Glicentin related purified peptide having 30 amino acids